Prognostic model for total mortality in patients with haemodialysis from the Assessments of Survival and Cardiovascular Events (AURORA) study

Journal of Internal Medicine

Volumn 271, Issue 5, 2012, Pages 463-471

  Holme, I ^a   Fellstrom B C ^b   Jardin, A G ^c   Schmieder, R E ^d   Zannad, F ^e,f   Holdaas, H ^g  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^e UNIVERSITÉ DE LORRAINE   (France)

^f UNIVERSITY HOSPITAL OF NANCY   (France)

^g OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Discrimination; Haemodialysis; Mortality; Prognostic study; Stratification

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

AGE FACTORS; AGED; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COMORBIDITY; DIABETES MELLITUS; FEMALE; HEMODIALYSIS UNITS, HOSPITAL; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RISK FACTORS; ROC CURVE; SERUM ALBUMIN;

EID: 84860259543     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2011.02435.x     Document Type: Article

References (16)

1. Goodkin DA, Young EW, Kurakawa K et al. Mortality among hemodialysis patients in Europe, Japan and the United States: case-mix effects. Am J Kidney Dis 2004; 44: 16-21.
2. Kessler M, Zannad F, Lehert P et al. Predictors of cardiovascular events in patients with end-stage renal disease: an analysis from the Fosinopril in Dialysis study. Nephrol Dial Transplant 2007; 22: 3573-9.
3. Johnson DW, Craven AM, Isbel NM. Modification of cardiovascular risk in hemodialysis patients: an evidence-based review. Hemodial Int 2007; 11: 1-14.
4. Middleton RJ, Parfrey PS, Foley RN. Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol 1995; 5: 1079-84.
5. Tripepi G, Mallamaci F, Zoccali C. Inflammation markers adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling. J Am Soc Nephrol 2005; 16(Suppl 1): S83-8.
6. Saran R, Bragg-Gresham JL, Levin NW et al. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 2006; 69: 1222-8.
7. Block GA, Klassen PS, Lazarus JM et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15: 2208-18.
8. Jardine AG, Fellström BC, Logan JO et al. Cardiovascular risk and renal transplantation: post hoc analysis of the Assessment of Lescol in Renal Transplantation (ALERT) study. Transplantation 2005; 46: 529-36.
9. Couchoud C, Lebeeuw M, Moranne O et al. A clinical score to predict 6-month prognosis in elderly patients stating dialysis for end-stage renal disease. Nephrol Dial Transplant 2009; 24: 1553-61.
10. Cohen L, Ruthazer R, Moss AH, Germain MJ. Predicting six-month mortality for patients who are on maintenance hemodialysis. Clin J Am Soc Nephrol 2010; 5: 72-9.
11. Lindholm B, Davies S. A new comorbidity index for estimating mortality risk in ESRD. Nat Rev Nephrol 2010; 6: 391-2.
12. Fellström BC, Jardine AG, Schmieder RE et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009; 360: 1395-407.
13. Suki WN, Zabaneh R, Cangiano Jl et al. Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Kidney Int 2007; 72: 1130-7.
14. Fellström B, Zannad F, Schmieder R et al. Effect of rosuvastatin on outcomes in chronic hemodialysis patients- design and rationale of the AURORA study. Curr Control Trials Cardiovasc Med 2005; 6: 9.
15. Fellström B, Holdaas H, Jardine AG et al. Effect of rosuvastatin on outcomes in chronic hemodialysis patients: baseline data from the AURORA study. Kidney Blood Press Res 2007; 30: 314-22.
16. Lemeshow S, Hosmer SW. The use of goodness-of-fit statistics in the development of logistic regression models. Am J Epidemiol 1982; 115: 92-106.